Physician profile
Thao Lai
NPI 1144956921
$660.19
in general payments reported to CMS, 2019-2025
18 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.18 · 2023: $238 · 2024: $192 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.43 | 2022-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $68.45 | 2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $47.60 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $44.67 | 2022 | |
| Sanofi-Aventis U.S. LLC | $44.51 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $43.72 | 2024-2025 | Verquvo |
| Boston Scientific Corporation | $36.36 | 2023 | Watchman Flx |
| Shionogi INC | $34.75 | 2023-2024 | Fetroja |
| Biotronik INC. | $31.92 | 2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Amgen INC. | $30.01 | 2023-2024 | Repatha |
| Lantheus Medical Imaging, INC. | $25.94 | 2024 | |
| Tactile Systems Technology INC | $16.47 | 2025 | Nimbl, Flexitouch Plus |
| Esperion Therapeutics, INC. | $16.30 | 2023 | Nexletol |
| Lilly USA, LLC | $15.97 | 2025 | Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.55 | 2023 | Lifevest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, Ltd. | $13.88 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $13.47 | 2025 | Camzyos |
| Scpharmaceuticals INC. | $13.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thao Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.